|
|
||||||||
Articles |
1
Departments of Chemical Pathology and
3
Rheumatology, Chase Farm Hospitals Trust, The Ridgeway, Enfield, Middlesex EN2 8JL, UK.
2
Department of the Care of the Elderly, Enfield
Community Care Trust, The Ridgeway, Enfield, Middlesex EN2 8JL, UK.
4
Eagle House Surgery, 291 High St., Ponders End,
Enfield, Middlesex EN3 4DN, UK.
5
North-East Thames Regional Immunoassay (NETRIA)
Laboratory, St. Bartholemew's Hospital & Medical College, 51/53
Bartholemew Close, London EC1A 7BE, UK.
a Author for correspondence. Fax 0181 342 0558; e-mail 100127.1142{at}compuserve.com
A novel interference with measurements of serum free thyroxine (FT4) caused by rheumatoid factor (RhF) is described. We found misleading, sometimes gross, increases of FT4 results in 5 clinically euthyroid elderly female patients with high RhF concentrations. All 5 patients had high FT4 on Abbott AxSYM® or IMx® analyzers. "NETRIA" immunoassays gave misleading results in 4 of the 5 patients; Amerlex-MAB® in 2 of 4 patients; AutoDELFIA®in 2 of the 5; and Corning ACS-180® and Bayer Diagnostics Immuno 1® in 1 of the 5. BM-ES700® system results for FT4 in these women remained within the reference range. Results for serum T4, thyroid-stimulating hormone, free triiodothyronine, thyroid-hormone-binding globulin, and FT4 measured by equilibrium dialysis were normal in all 5 patients. Drugs, albumin-binding variants, and anti-thyroid-hormone antibodies were excluded as interferences. Addition to normal serum of the RhF isolated from each of the 5 patients increased the apparent FT4 (Abbott AxSYM). Screening of 83 unselected patients demonstrated a highly significant positive correlation between FT4 (Abbott AxSYM) and RhF concentrations. Discrepant, apparently increased FT4 with a normal result for thyroid-stimulating hormone should lead to measurement of the patient's RhF concentration.
Key Words: indexing terms: hyperthyroidism rheumatoid arthritis fluoroimmunoassay polyethylene glycol affinity chromatography immunoabsorption equilibrium dialysis thyroid-stimulating hormone
The following articles in journals at HighWire Press have cited this article:
![]() |
A A A Ismail Interference from endogenous antibodies in automated immunoassays: what laboratorians need to know J. Clin. Pathol., August 1, 2009; 62(8): 673 - 678. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Marks False-Positive Immunoassay Results: A Multicenter Survey of Erroneous Immunoassay Results from Assays of 74 Analytes in 10 Donors from 66 Laboratories in Seven Countries Clin. Chem., November 1, 2002; 48(11): 2008 - 2016. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A.A. Ismail, P. L. Walker, J. H. Barth, K. C. Lewandowski, R. Jones, and W. A. Burr Wrong Biochemistry Results: Two Case Reports and Observational Study in 5310 Patients on Potentially Misleading Thyroid-stimulating Hormone and Gonadotropin Immunoassay Results Clin. Chem., November 1, 2002; 48(11): 2023 - 2029. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Ismail and J. H Barth Wrong biochemistry results BMJ, September 29, 2001; 323(7315): 705 - 706. [Full Text] [PDF] |
||||
![]() |
N. Despres and A. M. Grant Antibody interference in thyroid assays: a potential for clinical misinformation Clin. Chem., March 1, 1998; 44(3): 440 - 454. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |